Fate Therapeutics
FATE
#8485
Rank
โ‚น13.19 B
Marketcap
โ‚น115.13
Share price
1.50%
Change (1 day)
-67.85%
Change (1 year)

P/S ratio for Fate Therapeutics (FATE)

P/S ratio as of April 2025 (TTM): 11.4

According to Fate Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.4854. At the end of 2024 the company had a P/S ratio of 13.5.

P/S ratio history for Fate Therapeutics from 2013 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202413.5131.76%
20235.80-42.99%
202210.2-89.82%
2021100-60.36%
202025281.87%
2019139-20.75%
2018175123.55%
201778.3231.94%
201623.6-40.72%
201539.8
2014N/A-100%
2013132

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
3.15-72.24%๐Ÿ‡บ๐Ÿ‡ธ USA
2.84-74.94%๐Ÿ‡บ๐Ÿ‡ธ USA
4.84-57.32%๐Ÿ‡บ๐Ÿ‡ธ USA
341 2,906.17%๐Ÿ‡บ๐Ÿ‡ธ USA
4.44-60.86%๐Ÿ‡บ๐Ÿ‡ธ USA